Senores Pharmaceuticals Price to Sales Ratio (P/S)

Senores Pharmaceuticals Ltd Price to Sales Ratio

The Senores Pharmaceuticals Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Senores Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Senores Pharmaceuticals Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Senores Pharmaceuticals Ltd (NSE: SENORES, BSE: 544319) is currently trading at ₹784.25, with a market capitalization of ₹35.68B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Senores Pharmaceuticals Ltd Price to Sales Ratio is essential for fundamental analysis.

Senores Pharmaceuticals Ltd Price to Sales Ratio Current Value

The current Senores Pharmaceuticals Ltd Price to Sales Ratio stands at 5.24.

The latest Senores Pharmaceuticals Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Senores Pharmaceuticals Ltd Price to Sales Ratio Historical Trend

The Senores Pharmaceuticals Ltd Price to Sales Ratio has shown the following historical trend:

• 2024: 5.24
• 2023: 0
• 2022: 0
• 2021: 0

The recent rise in Senores Pharmaceuticals Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.

What Senores Pharmaceuticals Ltd Price to Sales Ratio Indicates for Investors

The Senores Pharmaceuticals Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Senores Pharmaceuticals Ltd Price to Sales Ratio Analysis Summary

The Senores Pharmaceuticals Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Senores Pharmaceuticals Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Senores Pharmaceuticals Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.